Tandem Diabetes Care ROE 2012-2024 | TNDM
Current and historical return on equity (ROE) values for Tandem Diabetes Care (TNDM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Tandem Diabetes Care ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $-0.13B | $0.24B | -49.37% |
| 2024-06-30 | $-0.14B | $0.23B | -49.59% |
| 2024-03-31 | $-0.14B | $0.24B | -47.33% |
| 2023-12-31 | $-0.22B | $0.31B | -68.83% |
| 2023-09-30 | $-0.21B | $0.31B | -58.79% |
| 2023-06-30 | $-0.23B | $0.33B | -58.82% |
| 2023-03-31 | $-0.20B | $0.34B | -49.42% |
| 2022-12-31 | $-0.10B | $0.44B | -21.73% |
| 2022-09-30 | $-0.07B | $0.42B | -15.61% |
| 2022-06-30 | $-0.01B | $0.45B | -3.04% |
| 2022-03-31 | $0.01B | $0.44B | 1.49% |
| 2021-12-31 | $0.02B | $0.43B | 4.32% |
| 2021-09-30 | $0.02B | $0.39B | 6.22% |
| 2021-06-30 | $0.01B | $0.35B | 2.07% |
| 2021-03-31 | $-0.02B | $0.31B | -7.54% |
| 2020-12-31 | $-0.03B | $0.37B | -11.64% |
| 2020-09-30 | $-0.05B | $0.33B | -19.26% |
| 2020-06-30 | $-0.04B | $0.27B | -20.07% |
| 2020-03-31 | $-0.02B | $0.21B | -9.52% |
| 2019-12-31 | $-0.03B | $0.20B | -15.92% |
| 2019-09-30 | $-0.02B | $0.17B | -17.02% |
| 2019-06-30 | $-0.06B | $0.15B | -42.97% |
| 2019-03-31 | $-0.11B | $0.12B | -113.99% |
| 2018-12-31 | $-0.12B | $0.13B | -171.83% |
| 2018-09-30 | $-0.14B | $0.12B | -441.94% |
| 2018-06-30 | $-0.12B | $0.03B | 2505.26% |
| 2018-03-31 | $-0.08B | $0.01B | 520.63% |
| 2017-12-31 | $-0.07B | $-0.03B | 379.22% |
| 2017-09-30 | $-0.08B | $-0.03B | 570.37% |
| 2017-06-30 | $-0.09B | $-0.02B | 1733.33% |
| 2017-03-31 | $-0.09B | $-0.00B | -1200.00% |
| 2016-12-31 | $-0.08B | $-0.01B | -431.17% |
| 2016-09-30 | $-0.08B | $0.01B | -219.18% |
| 2016-06-30 | $-0.07B | $0.03B | -132.08% |
| 2016-03-31 | $-0.07B | $0.05B | -107.46% |
| 2015-12-31 | $-0.07B | $0.06B | -90.12% |
| 2015-09-30 | $-0.08B | $0.07B | -100.00% |
| 2015-06-30 | $-0.08B | $0.09B | -101.28% |
| 2015-03-31 | $-0.08B | $0.10B | -101.30% |
| 2014-12-31 | $-0.08B | $0.06B | -104.29% |
| 2014-09-30 | $-0.09B | $0.07B | -93.41% |
| 2014-06-30 | $-0.08B | $0.08B | -106.12% |
| 2014-03-31 | $-0.07B | $0.10B | -135.16% |
| 2013-12-31 | $-0.06B | $0.12B | -206.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.267B | $0.748B |
| Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.393B | 24.93 |
| Intuitive Surgical (ISRG) | United States | $193.619B | 101.23 |
| Edwards Lifesciences (EW) | United States | $43.533B | 27.64 |
| Alcon (ALC) | Switzerland | $42.700B | 28.57 |
| IQVIA Holdings (IQV) | United States | $36.494B | 20.11 |
| IDEXX Laboratories (IDXX) | United States | $35.790B | 42.15 |
| DexCom (DXCM) | United States | $31.431B | 47.33 |
| Waters (WAT) | United States | $22.876B | 33.83 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.760B | 0.00 |
| Hologic (HOLX) | United States | $17.141B | 18.51 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.008B | 14.38 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.294B | 28.60 |
| Penumbra (PEN) | United States | $9.735B | 95.36 |
| Masimo (MASI) | United States | $9.336B | 45.18 |
| Teleflex (TFX) | United States | $8.528B | 13.60 |
| Glaukos (GKOS) | United States | $7.879B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.728B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.717B | 26.73 |
| Inari Medical (NARI) | United States | $3.408B | 0.00 |
| Veracyte (VCYT) | United States | $3.372B | 101.19 |
| LivaNova (LIVN) | United Kingdom | $2.796B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.337B | 17.75 |
| TransMedics (TMDX) | United States | $2.261B | 71.66 |
| Elekta AB (EKTAY) | Sweden | $2.229B | 20.04 |
| Integra LifeSciences Holdings (IART) | United States | $1.864B | 9.74 |
| RxSight (RXST) | United States | $1.515B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.254B | 83.11 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.062B | 0.00 |
| Paragon 28 (FNA) | United States | $0.874B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.708B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 16.49 |
| IRadimed (IRMD) | United States | $0.699B | 37.80 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.558B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 31.48 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.453B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.440B | 23.83 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.331B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.230B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Nevro (NVRO) | United States | $0.162B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.12 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.011B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |